Aicuris Presents Positive Phase 2 Results for Pritelivir and Favorable Phase 1 Safety Data ...

Results from pritelivir Phase 2 study demonstrate a favorable safety profile and a numerically higher lesion healing rate vs. foscarnetPritelivir ...